[Not Available].

Journal: Zeitschrift fur medizinische Physik
PMID:

Abstract

BACKGROUND: Currently there is an ever increasing interest in Lu-177 targeted radionuclide therapies, which target neuro-endocrine and prostate tumours. For a patient-specific treatment, an individual dosimetry based on SPECT/CT imaging is necessary. The aim of this study is to introduce a dosimetry method, where dose voxel kernels (DVK) are predicted by a neural network.

Authors

  • Theresa I Götz
    Clinic of Nuclear Medicine, University Hospital Erlangen, 91054 Erlangen, Germany; CIML Group, Biophysics, University of Regensburg, 93040 Regensburg, Germany; Information Sciences, University of Regensburg, 93053 Regensburg, Germany. Electronic address: theresa.goetz@biologie.uni-regensburg.de.
  • Elmar W Lang
    CIML Group, Biophysics, University of Regensburg, 93040 Regensburg, Germany.
  • Christian Schmidkonz
    Clinic of Nuclear Medicine, University Hospital Erlangen, 91054 Erlangen, Germany.
  • Torsten Kuwert
    Department of Nuclear Medicine, Universitätsklinikum Erlangen, 91054 Erlangen, Germany. Electronic address: torsten.kuwert@uk-erlangen.de.
  • Bernd Ludwig
    Information Sciences, University of Regensburg, 93053 Regensburg, Germany.